Literature DB >> 11274685

Age specificity of the relationship between serum cholesterol and mood in obese women.

A Troisi1, S Scucchi, L San Martino, P Montera, A d'Amore, A Moles.   

Abstract

Despite increasing evidence of an association between lower cholesterol levels and negative mood, no study has specifically investigated this relationship in obese people, a population at high risk for both dyslipidaemia and depression. Data on serum cholesterol and mood were collected in a group of 73 healthy women, aged 16 to 76 years, with different degrees of obesity and widely varying total cholesterol concentrations. Mood was assessed using three self-rated scales: the Toronto Alexithymia Scale (TAS-20), the State-Trait Anger Scale (STAS), and the Beck Depression Inventory (BDI). The association between lower total cholesterol levels and negative mood was age-dependent. No significant association was found in the younger age group (<50 years). In contrast, in the subgroup of older women, serum cholesterol was negatively and significantly correlated with the TAS-20 and the STAS. The negative correlation between serum cholesterol and the BDI was nearly statistically significant. Restricting analysis to the subjects in the highest quartile of the age distribution (>60 years) yielded stronger correlations between cholesterol and mood. In this sample of obese women, the relationship between lower cholesterol levels and negative mood was age-specific and limited to the older age group. The results of this study suggest that preventive programs or drug treatments for reducing cholesterol levels in elderly obese women should include a careful evaluation of mood state.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274685     DOI: 10.1016/s0031-9384(00)00422-4

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  2 in total

Review 1.  Depression and obesity among females, are sex specificities considered?

Authors:  Ingrid Baldini; Breno P Casagrande; Debora Estadella
Journal:  Arch Womens Ment Health       Date:  2021-04-20       Impact factor: 3.633

2.  Development of a dosing strategy for enoxaparin in obese patients.

Authors:  Bruce Green; Stephen B Duffull
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.